AAAAAA

   
Results: 1-14 |
Results: 14
Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy
Authors: Wong, ECC Maher, VE Hines, K Lee, J Carter, CS Goletz, T Kopp, W Mackall, CL Berzofsky, JA Read, EJ
Citation: Ecc. Wong et al., Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy, CYTOTHERAPY, 3(1), 2001, pp. 19-29
Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
Authors: Horwitz, ME Barrett, AJ Brown, MR Carter, CS Childs, R Gallin, JI Gress, RE Holland, SM Linton, GF Miller, JA Leitman, SF Read, EJ Schermerhorn, J Malech, HL
Citation: Me. Horwitz et al., Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft., N ENG J MED, 344(12), 2001, pp. 881-888
Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral bloodstem cell transplants with delayed donor lymphocyte add-back
Authors: Nakamura, R Bahceci, E Read, EJ Leitman, SF Carter, CS Childs, R Dunbar, CE Gress, R Altemus, R Young, NS Barrett, AJ
Citation: R. Nakamura et al., Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral bloodstem cell transplants with delayed donor lymphocyte add-back, BR J HAEM, 115(1), 2001, pp. 95-104
Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution?
Authors: Husebekk, A Fellowes, V Read, EJ Williams, J Petrus, MJ Gress, RE Fowler, DH
Citation: A. Husebekk et al., Selection and expansion of T cells from untreated patients with CLL: source of cells for immune reconstitution?, CYTOTHERAPY, 2(3), 2000, pp. 187-193
Database use patterns in public libraries
Authors: Tenopir, C Read, EJ
Citation: C. Tenopir et Ej. Read, Database use patterns in public libraries, REF USER S, 40(1), 2000, pp. 39-52
Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
Authors: Childs, R Chernoff, A Contentin, N Bahceci, E Schrump, D Leitman, S Read, EJ Tisdale, J Dunbar, C Linehan, WM Young, NS Barrett, AJ Clave, E Epperson, D Mayo, V
Citation: R. Childs et al., Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation, N ENG J MED, 343(11), 2000, pp. 750-758
CD34+cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies
Authors: Bahceci, E Read, EJ Leitman, S Childs, R Dunbar, C Young, NS Barrett, AJ
Citation: E. Bahceci et al., CD34+cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies, BR J HAEM, 108(2), 2000, pp. 408-414
Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults
Authors: Mackall, CL Stein, D Fleisher, TA Brown, MR Hakim, FT Bare, CV Leitman, SF Read, EJ Carter, CS Wexler, LH Gress, RE
Citation: Cl. Mackall et al., Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults, BLOOD, 96(2), 2000, pp. 754-762
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing themultidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients
Authors: Cowan, KH Moscow, JA Huang, H Zujewski, JA O'Shaughnessy, J Sorrentino, B Hines, K Carter, C Schneider, E Cusack, G Noone, M Dunbar, C Steinberg, S Wilson, W Goldspiel, B Read, EJ Leitman, SF McDonagh, K Chow, C Abati, A Chiang, Y Chang, YN Gottesman, MM Pastan, I Nienhuis, A
Citation: Kh. Cowan et al., Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing themultidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients, CLIN CANC R, 5(7), 1999, pp. 1619-1628
Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC)
Authors: Liu, JM Kim, S Read, EJ Futaki, M Dokal, I Carter, CS Leitman, SF Pensiero, M Young, NS Walsh, CE
Citation: Jm. Liu et al., Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC), HUM GENE TH, 10(14), 1999, pp. 2337-2346
Fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous FasL-expressing T cells
Authors: Williams, JF Petrus, MJ Wright, JA Husebekk, A Fellowes, V Read, EJ Gress, RE Fowler, DH
Citation: Jf. Williams et al., Fas-mediated lysis of chronic lymphocytic leukaemia cells: role of type I versus type II cytokines and autologous FasL-expressing T cells, BR J HAEM, 107(1), 1999, pp. 99-105
Human G-CSF-mobilized CD34-positive peripheral blood progenitor cells callstimulate allogeneic T-cell responses: implications for graft rejection inmismatched transplantation
Authors: van Rhee, F Jiang, YZ Vigue, F Kirby, M Mavroudis, D Hensel, NF Agarwala, V Clave, E Childs, R Raptis, A Sloand, E Carter, C Read, EJ Barrett, J
Citation: F. Van Rhee et al., Human G-CSF-mobilized CD34-positive peripheral blood progenitor cells callstimulate allogeneic T-cell responses: implications for graft rejection inmismatched transplantation, BR J HAEM, 105(4), 1999, pp. 1014-1024
Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses
Authors: Childs, R Clave, E Contentin, N Jayasekera, D Hensel, N Leitman, S Read, EJ Carter, C Bahceci, E Young, NS Barrett, AJ
Citation: R. Childs et al., Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: Full donor T-cell chimerism precedes alloimmune responses, BLOOD, 94(9), 1999, pp. 3234-3241
Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy
Authors: Moscow, JA Huang, H Carter, C Hines, K Zujewski, J Cusack, G Chow, C Venzon, D Sorrentino, B Chiang, YW Goldspiel, B Leitman, S Read, EJ Abati, A Gottesman, MM Pastan, I Sellers, S Dunbar, C Cowan, KH
Citation: Ja. Moscow et al., Engraftment of MDR1 and NeoR gene-transduced hematopoietic cells after breast cancer chemotherapy, BLOOD, 94(1), 1999, pp. 52-61
Risultati: 1-14 |